Methotrexate Drugs Market Size

Methotrexate Drugs Market Size

Methotrexate Drugs Market size was valued at around USD 590.4 million in 2023 and is estimated to grow at 3.1% CAGR from 2024 to 2032. Methotrexate drugs is a versatile medication with a wide range of therapeutic applications. Originally developed as a chemotherapy agent for treating cancer, it has since found extensive use in the management of autoimmune disorders and inflammatory conditions due to its immunosuppressive and anti-inflammatory properties.

To get key market trends

  Download Free Sample

It works by inhibiting the enzymes dihydrofolate reductase, which is involved in the synthesis of DNA, RNA, and proteins. By interfering with folate metabolism, methotrexate disrupts the proliferation of rapidly dividing cells, including cancer cells and cells of the immune system responsible for inflammation in autoimmune diseases.
 

The rising prevalence of cancer is a significant driving factors for the market. For instance, according to the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths worldwide. Thus, this underscores the urgent need for effective treatments such as cancer immunotherapy, driving its demand and market growth.
 

Furthermore, ongoing research and development using methotrexate, which is estimated to reach USD 921 million by 2032, drugs, rising technological advancements and demand for personalized medicine, are the promoting factors fostering the growth of the market.